Updates of precision medicine in type 2 diabetes
Diabetes mellitus is prevalent worldwide and affects 1 in 10 adults. Despite the successful development of glucose-lowering drugs, such as glucagon-like peptide-1 (GLP-1) receptor agonists and sodium-glucose cotransporter-2 inhibitors recently, the proportion of patients achieving satisfactory gluco...
Saved in:
Main Authors: | Mingfeng Xia (Author), Xiaoying Li (Author) |
---|---|
Format: | Book |
Published: |
Cambridge University Press,
2023-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Advancements in precision medicine: multi-omics approach for tailored metformin treatment in type 2 diabetes
by: Najeha Rizwana Anwardeen, et al.
Published: (2024) -
Systems Pharmacology and Network Analysis to Advance Pharmacogenomics and Precision Medicine Decisions in Type-2 Diabetes Therapy
by: Aikaterini Saiti, et al.
Published: (2023) -
Exercise as 'precision medicine' for insulin resistance and its progression to type 2 diabetes: a research review
by: Fred J. DiMenna, et al.
Published: (2018) -
From precision medicine to precision care: Choosing and using precision medicine in the context of multimorbidity
by: Arlene S. Bierman, et al.
Published: (2023) -
Epitope-based precision immunotherapy of Type 1 diabetes
by: Rebuma Firdessa Fite, et al.
Published: (2023)